過去の学術活動等

1: Srivastava T, Garola RE, Zhou J, Boinpelly VC, Rezaiekhaligh MH, Joshi T, Jiang Y, Ebadi D, Sharma S, Sethna C, Staggs VS, Sharma R, Gipson DS, Hao W, Wang Y, Mariani LH, Hodgin JB, Rottapel R, Yoshitaka T, Ueki Y, Sharma M. Scaffold protein SH3BP2 signalosome is pivotal for immune activation in nephrotic syndrome. JCI Insight. 2024 Feb 8;9(3):e170055. doi: 10.1172/jci.insight.170055. PMID: 38127456; PMCID: PMC10967477.

2: Yoshitaka T, Shimaoka Y, Yamanaka I, Tanida A, Tanimoto J, Toda N, Akimori T, Hamawaki J. Cognitive Impairment as the Principal Factor Correlated with the Activities of Daily Living Following Hip Fracture in Elderly People. Prog Rehabil Med. 2022 May 18;7:20220026. doi: 10.2490/prm.20220026. PMID: 35633759; PMCID: PMC9110876.

3: Kittaka M, Mayahara K, Mukai T, Yoshimoto T, Yoshitaka T, Gorski JP, Ueki Y. Cherubism Mice Also Deficient in c-Fos Exhibit Inflammatory Bone Destruction Executed by Macrophages That Express MMP14 Despite the Absence of TRAP+ Osteoclasts. J Bone Miner Res. 2018 Jan;33(1):167-181. doi: 10.1002/jbmr.3295. Epub 2017 Nov 2. PMID: 28914985; PMCID: PMC5771992.

4: Mukai T, Gallant R, Ishida S, Kittaka M, Yoshitaka T, Fox DA, Morita Y, Nishida K, Rottapel R, Ueki Y. Loss of SH3 domain-binding protein 2 function suppresses bone destruction in tumor necrosis factor-driven and collagen-induced arthritis in mice. Arthritis Rheumatol. 2015 Mar;67(3):656-67. doi: 10.1002/art.38975. PMID: 25470448; PMCID: PMC4342302.

5: Yoshitaka T, Kittaka M, Ishida S, Mizuno N, Mukai T, Ueki Y. Bone marrow transplantation improves autoinflammation and inflammatory bone loss in SH3BP2 knock-in cherubism mice. Bone. 2015 Feb;71:201-9. doi: 10.1016/j.bone.2014.10.021. Epub 2014 Oct 31. PMID: 25445458; PMCID: PMC4274253.

6: Yoshitaka T, Mukai T, Kittaka M, Alford LM, Masrani S, Ishida S, Yamaguchi K, Yamada M, Mizuno N, Olsen BR, Reichenberger EJ, Ueki Y. Enhanced TLR-MYD88 signaling stimulates autoinflammation in SH3BP2 cherubism mice and defines the etiology of cherubism. Cell Rep. 2014 Sep 25;8(6):1752-1766. doi: 10.1016/j.celrep.2014.08.023. Epub 2014 Sep 15. PMID: 25220465; PMCID:PMC4177302.

7: Mukai T, Gallant R, Ishida S, Yoshitaka T, Kittaka M, Nishida K, Fox DA, Morita Y, Ueki Y. SH3BP2 gain-of-function mutation exacerbates inflammation and bone loss in a murine collagen-induced arthritis model. PLoS One. 2014 Aug 21;9(8):e105518. doi: 10.1371/journal.pone.0105518. PMID: 25144740; PMCID: PMC4140794.

8: Yoshitaka T, Ishida S, Mukai T, Kittaka M, Reichenberger EJ, Ueki Y. Etanercept administration to neonatal SH3BP2 knock-in cherubism mice prevents TNF-α-induced inflammation and bone loss. J Bone Miner Res. 2014;29(5):1170-82. doi: 10.1002/jbmr.2125. PMID: 24978678; PMCID: PMC4131552.

9: Mukai T, Ishida S, Ishikawa R, Yoshitaka T, Kittaka M, Gallant R, Lin YL, Rottapel R, Brotto M, Reichenberger EJ, Ueki Y. SH3BP2 cherubism mutation potentiates TNF-α-induced osteoclastogenesis via NFATc1 and TNF-α-mediated inflammatory bone loss. J Bone Miner Res. 2014 Dec;29(12):2618-35. doi: 10.1002/jbmr.2295. PMID: 24916406; PMCID: PMC4262741.

10: Yoshitaka T, Kawai A, Miyaki S, Numoto K, Kikuta K, Ozaki T, Lotz M, Asahara H. Analysis of microRNAs expressions in chondrosarcoma. J Orthop Res. 2013 Dec;31(12):1992-8. doi: 10.1002/jor.22457. Epub 2013 Aug 12. PMID: 23940002; PMCID: PMC3835201.

11: Ito Y, Toriuchi N, Yoshitaka T, Ueno-Kudoh H, Sato T, Yokoyama S, Nishida K, Akimoto T, Takahashi M, Miyaki S, Asahara H. The Mohawk homeobox gene is a critical regulator of tendon differentiation. Proc Natl Acad Sci U S A. 2010 Jun 8;107(23):10538-42. doi: 10.1073/pnas.1000525107. Epub 2010 May 24. PMID: 20498044; PMCID: PMC2890854.

12: Takigawa T, Yonezawa T, Yoshitaka T, Minaguchi J, Kurosaki M, Tanaka M, Sado Y, Ohtsuka A, Ozaki T, Ninomiya Y. Separation of the perivascular basement membrane provides a conduit for inflammatory cells in a mouse spinal cord injury model. J Neurotrauma. 2010 Apr;27(4):739-51. doi: 10.1089/neu.2009.1111. PMID: 20038195.

13: Higashiyama R, Miyaki S, Yamashita S, Yoshitaka T, Lindman G, Ito Y, Sasho T, Takahashi K, Lotz M, Asahara H. Correlation between MMP-13 and HDAC7 expression in human knee osteoarthritis. Mod Rheumatol. 2010 Feb;20(1):11-7. doi: 10.1007/s10165-009-0224-7. Epub 2009 Sep 26. PMID: 19784544; PMCID: PMC2818344.

14: Yoshitaka T, Abe N, Minagawa H, Date H, Sakoma Y, Nishida K, Ozaki T. Disease-specific screening for deep venous thrombosis and pulmonary thromboembolism using plasma D-dimer values after total knee arthroplasty. Mod Rheumatol. 2008;18(4):359-65. doi: 10.1007/s10165-008-0068-6. Epub 2008 May 8. PMID: 18461274.

15: Yonezawa T, Ohtsuka A, Yoshitaka T, Hirano S, Nomoto H, Yamamoto K, Ninomiya Y. Limitrin, a novel immunoglobulin superfamily protein localized to glia limitans formed by astrocyte endfeet. Glia. 2003 Dec;44(3):190-204. doi: 10.1002/glia.10279. PMID: 14603461.

16: Yoshitaka T, Mitani S, Aoki K, Miyake A, Inoue H. Long-term follow-up of congenital subluxation of the hip. J Pediatr Orthop. 2001 Jul-Aug;21(4):474-80. PMID: 11433160.

17: Akazawa H, Oda K, Mitani S, Yoshitaka T, Asaumi K, Inoue H. Surgical management of hip dislocation in children with arthrogryposis multiplex congenita. J Bone Joint Surg Br. 1998 Jul;80(4):636-40. doi: 10.1302/0301-620x.80b4.8216. PMID: 9699827.

18: Ozaki T, Yoshitaka T, Kunisada T, Dan'ura T, Naito N, Inoue H. Vancomycin- impregnated polymethylmethacrylate beads for methicillin-resistant Staphylococcus aureus (MRSA) infection: report of two cases. J Orthop Sci. 1998;3(3):163-8. doi: 10.1007/s007760050037. PMID: 9683770.

19: Yoshioka H, Yoshitaka T. [Chondrodysplasia]. Ryoikibetsu Shokogun Shirizu. 1998;(19 Pt 2):518-21. Japanese. PMID: 9645124.

20: Yoshitaka T, Yoshioka H. [Osteogenesis imperfecta]. Ryoikibetsu Shokogun Shirizu. 1998;(19 Pt 2):510-3. Japanese. PMID: 9645122.